메뉴 건너뛰기




Volumn 25, Issue 6, 2014, Pages 1184-1192

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway andmicrotubule network with therapeutic implications

Author keywords

Epothilone B; MAD2L1; Mesothelioma; Microarray; Network; Therapeutics

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; EPOTHILONE B; MITOTIC ARREST DEFICIENT LIKE 1 PROTEIN; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; EPOTHILONE DERIVATIVE; MAD2L1BP PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUBULIN MODULATOR;

EID: 84903885439     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu127     Document Type: Article
Times cited : (48)

References (27)
  • 2
    • 28444498381 scopus 로고    scopus 로고
    • Prognostic factors for mesothelioma
    • Steele JP. Prognostic factors for mesothelioma. Hematol Oncol Clin North Am 2005; 19: 1041-1052, vi.
    • (2005) Hematol Oncol Clin North Am , vol.19
    • Steele, J.P.1
  • 3
    • 58149083475 scopus 로고    scopus 로고
    • Systemic treatments for mesothelioma: standard and novel
    • Kindler HL. Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol 2008; 9: 171-179.
    • (2008) Curr Treat Options Oncol , vol.9 , pp. 171-179
    • Kindler, H.L.1
  • 4
    • 12444273659 scopus 로고    scopus 로고
    • Gene expression profiling of malignant mesothelioma
    • Singhal S, Wiewrodt R, Malden LD et al. Gene expression profiling of malignant mesothelioma. Clin Cancer Res 2003; 9: 3080-3097.
    • (2003) Clin Cancer Res , vol.9 , pp. 3080-3097
    • Singhal, S.1    Wiewrodt, R.2    Malden, L.D.3
  • 5
    • 21144456382 scopus 로고    scopus 로고
    • Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using largescale transcriptional profiling
    • Gordon GJ, Rockwell GN, Jensen RV et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using largescale transcriptional profiling. Am J Pathol 2005; 166: 1827-1840.
    • (2005) Am J Pathol , vol.166 , pp. 1827-1840
    • Gordon, G.J.1    Rockwell, G.N.2    Jensen, R.V.3
  • 6
    • 33645515866 scopus 로고    scopus 로고
    • Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
    • Lopez-Rios F, Chuai S, Flores R et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 2006; 66: 2970-2979.
    • (2006) Cancer Res , vol.66 , pp. 2970-2979
    • Lopez-Rios, F.1    Chuai, S.2    Flores, R.3
  • 7
    • 70349277287 scopus 로고    scopus 로고
    • Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target
    • Crispi S, Calogero RA, Santini M et al. Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One 2009; 4: e7016.
    • (2009) PLoS One , vol.4
    • Crispi, S.1    Calogero, R.A.2    Santini, M.3
  • 8
    • 84880273681 scopus 로고    scopus 로고
    • Molecular pathogenesis of malignant mesothelioma
    • Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 2013; 34: 1413-1419.
    • (2013) Carcinogenesis , vol.34 , pp. 1413-1419
    • Sekido, Y.1
  • 9
    • 71849098457 scopus 로고    scopus 로고
    • Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
    • Sekido Y. Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci 2010; 101: 1-6.
    • (2010) Cancer Sci , vol.101 , pp. 1-6
    • Sekido, Y.1
  • 10
    • 80052356301 scopus 로고    scopus 로고
    • Advances in the biology of malignant pleural mesothelioma
    • Zucali PA, Ceresoli GL, De Vincenzo F et al. Advances in the biology of malignant pleural mesothelioma. Cancer Treat Rev 2011; 37: 543-558.
    • (2011) Cancer Treat Rev , vol.37 , pp. 543-558
    • Zucali, P.A.1    Ceresoli, G.L.2    De Vincenzo, F.3
  • 11
    • 79955562300 scopus 로고    scopus 로고
    • Review on clinical trials of targeted treatments in malignant mesothelioma
    • Jakobsen JN, Sorensen JB. Review on clinical trials of targeted treatments in malignant mesothelioma. Cancer Chemother Pharmacol 2011; 68: 1-15.
    • (2011) Cancer Chemother Pharmacol , vol.68 , pp. 1-15
    • Jakobsen, J.N.1    Sorensen, J.B.2
  • 12
    • 15744373791 scopus 로고    scopus 로고
    • Pathology and Genetics of Tumours of the Lung, Pleura
    • Thymus Heart. IARC World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer (IARC)
    • Travis WD, M-HHK BE, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura. Thymus Heart. IARC World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer (IARC), 2004.
    • (2004)
    • Travis, W.D.1    M-Hhk, B.E.2    Harris, C.C.3
  • 13
    • 34247333444 scopus 로고    scopus 로고
    • The spindle-assembly checkpoint in space and time
    • Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8: 379-393.
    • (2007) Nat Rev Mol Cell Biol , vol.8 , pp. 379-393
    • Musacchio, A.1    Salmon, E.D.2
  • 14
    • 0036018904 scopus 로고    scopus 로고
    • Malignant pleural mesothelioma: a phase II trial with docetaxel
    • Vorobiof DA, Rapoport BL, Chasen MR et al. Malignant pleural mesothelioma: a phase II trial with docetaxel. Ann Oncol 2002; 13: 412-415.
    • (2002) Ann Oncol , vol.13 , pp. 412-415
    • Vorobiof, D.A.1    Rapoport, B.L.2    Chasen, M.R.3
  • 15
    • 45549107234 scopus 로고    scopus 로고
    • Novel cytotoxic agents: epothilones
    • Goodin S. Novel cytotoxic agents: epothilones. Am J Health Syst Pharm 2008; 65: S10-S15.
    • (2008) Am J Health Syst Pharm , vol.65
    • Goodin, S.1
  • 16
    • 33845986330 scopus 로고    scopus 로고
    • Mad2 overexpression promotes aneuploidy and tumorigenesis in mice
    • Sotillo R, Hernando E, Diaz-Rodriguez E et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11: 9-23.
    • (2007) Cancer Cell , vol.11 , pp. 9-23
    • Sotillo, R.1    Hernando, E.2    Diaz-Rodriguez, E.3
  • 17
    • 77949773695 scopus 로고    scopus 로고
    • Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
    • Sotillo R, Schvartzman JM, Socci ND et al. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010; 464: 436-440.
    • (2010) Nature , vol.464 , pp. 436-440
    • Sotillo, R.1    Schvartzman, J.M.2    Socci, N.D.3
  • 18
    • 79958733630 scopus 로고    scopus 로고
    • Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition
    • Schvartzman JM, Duijf PH, Sotillo R et al. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011; 19: 701-714.
    • (2011) Cancer Cell , vol.19 , pp. 701-714
    • Schvartzman, J.M.1    Duijf, P.H.2    Sotillo, R.3
  • 19
    • 78650569571 scopus 로고    scopus 로고
    • Phosphorylation of the spindle checkpoint protein Mad2 regulates its conformational transition
    • Kim S, Sun H, Ball HL et al. Phosphorylation of the spindle checkpoint protein Mad2 regulates its conformational transition. Proc Natl Acad Sci USA 2010; 107: 19772-19777.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 19772-19777
    • Kim, S.1    Sun, H.2    Ball, H.L.3
  • 20
    • 0033758034 scopus 로고    scopus 로고
    • Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells
    • Percy MJ, Myrie KA, Neeley CK et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 2000; 29: 356-362.
    • (2000) Genes Chromosomes Cancer , vol.29 , pp. 356-362
    • Percy, M.J.1    Myrie, K.A.2    Neeley, C.K.3
  • 21
    • 62549089719 scopus 로고    scopus 로고
    • Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies
    • Bolanos-Garcia VM. Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies. Curr Cancer Drug Targets 2009; 9: 131-141.
    • (2009) Curr Cancer Drug Targets , vol.9 , pp. 131-141
    • Bolanos-Garcia, V.M.1
  • 22
    • 79953299183 scopus 로고    scopus 로고
    • Drugs that target dynamic microtubules: a new molecular perspective
    • Stanton RA, Gernert KM, Nettles JH et al. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 2011; 31: 443-481.
    • (2011) Med Res Rev , vol.31 , pp. 443-481
    • Stanton, R.A.1    Gernert, K.M.2    Nettles, J.H.3
  • 23
    • 78049423380 scopus 로고    scopus 로고
    • Ixabepilone, a new treatment option for metastatic breast cancer
    • Toppmeyer DL, Goodin S. Ixabepilone, a new treatment option for metastatic breast cancer. Am J Clin Oncol 2010; 33: 516-521.
    • (2010) Am J Clin Oncol , vol.33 , pp. 516-521
    • Toppmeyer, D.L.1    Goodin, S.2
  • 24
    • 85027951919 scopus 로고    scopus 로고
    • Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
    • Rogalska A, Marczak A, Gajek A et al. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicol In Vitro 2013; 27: 239-249.
    • (2013) Toxicol In Vitro , vol.27 , pp. 239-249
    • Rogalska, A.1    Marczak, A.2    Gajek, A.3
  • 25
    • 0034518173 scopus 로고    scopus 로고
    • Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics
    • Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol 2000; 16: 89-111.
    • (2000) Annu Rev Cell Dev Biol , vol.16 , pp. 89-111
    • Downing, K.H.1
  • 26
    • 84859169877 scopus 로고    scopus 로고
    • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    • Barretina J, Caponigro G, Stransky N et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-607.
    • (2012) Nature , vol.483 , pp. 603-607
    • Barretina, J.1    Caponigro, G.2    Stransky, N.3
  • 27
    • 84876563391 scopus 로고    scopus 로고
    • Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
    • Yang W, Soares J, Greninger P et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013; 41: D955-D961.
    • (2013) Nucleic Acids Res , vol.41
    • Yang, W.1    Soares, J.2    Greninger, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.